MRI Could Spare Rectal Cancer Patients Invasive Surgery

New research from UVA Cancer Center offers hope for rectal cancer patients, suggesting that magnetic resonance imaging (MRI) could help them avoid invasive surgery and its lifelong side effects. The findings, led by Dr. Arun Krishnaraj, MPH, a radiologist and imaging expert, indicate that MRI can accurately predict patient outcomes and the risk of cancer recurrence or spread after chemotherapy and radiation.

A “Watch and Wait” Approach

This breakthrough could revolutionize treatment plans. Doctors can now use MRI to determine if a patient is truly cancer-free or if any residual disease remains. If MRI shows no signs of remaining cancer, patients may be eligible for a “watch and wait” approach, where their progress is closely monitored without immediate surgery. This option can provide peace of mind and avoid the potentially life-changing consequences of surgery.

“After undergoing chemotherapy and radiation for rectal cancer, patients are understandably concerned whether their cancer is gone or whether there may be some leftover disease,” explains Dr. Krishnaraj. “Using newer MRI techniques, we are now able to predict much better than in the past whether any cancer remains and, if so, whether it will come back and spread. No one wants to get surgery if they can avoid it. Now we have a powerful tool to help patients and their doctors predict who would benefit from surgery after initial chemotherapy and radiation and who can likely avoid surgery.”

The Importance of Early Detection

Rectal cancer is a growing concern, particularly among younger adults. The American Cancer Society estimates that about 1 in 23 men and 1 in 25 women will develop colorectal cancer in their lifetime. While radiation and chemotherapy are often the first line of treatment, some patients require extensive surgery known as “total mesorectal excision.” This procedure can be lifesaving but often results in significant side effects, including the need for a colostomy bag and sexual dysfunction.

A Powerful Tool for Personalized Care

The study’s findings suggest that MRI can effectively predict patient survival, cancer recurrence, and the likelihood of preserving the bowel. Combining MRI with data from endoscopies after treatment could further enhance its accuracy, offering doctors and patients even more precise information about potential outcomes.

“I am optimistic that continued advancement in MRI and other tools like endoscopy will provide better information about future outcomes,” Dr. Krishnaraj says. “Ultimately, I would love to get close to 99% predictive probability in better informing our patients about their potential risk for recurrence or spread of their cancers following treatment. We may not be there quite yet, but that is our goal.”

At UVA Cancer Center, a National Cancer Institute-designated Comprehensive Cancer Center, improving patient care is paramount. This research represents a significant step forward in providing personalized and less invasive treatment options for rectal cancer patients.

Ready to learn more about your options for rectal cancer treatment? Consult with a qualified healthcare professional to discuss the latest advancements and determine the best course of action for your individual needs.